Falkay G et al. Binding properties of beta-adrenergic receptors in early human fetal lung. (1986) BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 0006-291X 1090-2104 135 3 816-822,
1914963
NIJKAMP FP et al. MECHANISMS OF BETA-ADRENERGIC-RECEPTOR REGULATION IN LUNGS AND ITS IMPLICATIONS FOR PHYSIOLOGICAL-RESPONSES. (1992) PHYSIOLOGICAL REVIEWS 0031-9333 1522-1210 72 2 323-367
DAVIS DJ et al. BETA-ADRENERGIC RECEPTORS AND CAMP RESPONSE INCREASE DURING EXPLANT CULTURE OF HUMAN FETAL LUNG - PARTIAL INHIBITION BY DEXAMETHASONE. (1990) PEDIATRIC RESEARCH 0031-3998 1530-0447 28 3 190-195
WHITSETT JA et al. INDUCTION OF SURFACTANT PROTEIN IN FETAL LUNG - EFFECTS OF CAMP AND DEXAMETHASONE ON SAP-35 RNA AND SYNTHESIS. (1987) JOURNAL OF BIOLOGICAL CHEMISTRY 0021-9258 1083-351X 262 11 5256-5261
DAVIS DJ et al. BETA-ADRENERGIC RECEPTORS AND CYCLIC ADENOSINE-MONOPHOSPHATE GENERATION IN HUMAN-FETAL LUNG. (1987) PEDIATRIC RESEARCH 0031-3998 1530-0447 21 2 142-147
Pepperell JR et al. The type 1 angiotensin-II receptor mediates intracellular calcium mobilization in rat luteal cells. (1993) ENDOCRINOLOGY 0013-7227 1945-7170 133 4 1678-1684,
2344411
Michel MC et al. A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists. (2013) PHARMACOLOGICAL REVIEWS 0031-6997 1521-0081 65 2 809-848
Galan-Ocana A et al. Regulation of aminopeptidases by the renin-angiotensin system: monitoring seasonal variations in red deer and fallow deer from a Mediterranean ecosystem. (2012) ANIMAL PRODUCTION SCIENCE 1836-0939 1836-5787 52 8 761-765
Carrera MD et al. Ovarian Renin-Angiotensin System-regulating Aminopeptidases Are Involved in Progesterone Overproduction in Rats with Mammary Tumours Induced by N-Methyl Nitrosourea. (2009) ANTICANCER RESEARCH 0250-7005 1791-7530 29 11 4633-4637
de la Chica-Rodriguez et al. Doxazosin blockade of alpha(1)-adrenergic receptors increases rat serum progesterone levels: a putative role of ovarian angiotensin III in steroidogenesis. (2007) FERTILITY AND STERILITY 0015-0282 88 1071-1075
Tatsukawa Y et al. Possible roles of intracellular cyclic AMP, protein kinase C and calcium ion in the apoptotic signaling pathway in bovine luteal cells. (2006) JOURNAL OF REPRODUCTION AND DEVELOPMENT 0916-8818 1348-4400 52 4 517-522
de Gooyer TE et al. Angiotensin II influences ovarian follicle development in the transgenic (mRen-2)27 and Sprague-Dawley rat. (2004) JOURNAL OF ENDOCRINOLOGY 0022-0795 1479-6805 180 2 311-324
Brunswig-Spickenheier B et al. Local regulatory factors in regulation of ovarian function: Role of prorenin-renin-angiotensin-system. (2003) INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY 0019-5189 0975-1009 41 7 669-681
Hayashi K et al. The cooperative action of angiotensin II with subluteolytic administration of PGF(2 alpha) in inducing luteolysis and oestrus in the cow. (2002) REPRODUCTION 1470-1626 1741-7899 124 2 311-315
Greco S et al. AT1 angiotensin II receptor mediates intracellular calcium mobilization in normal and cancerous breast cells in primary culture. (2002) CELL CALCIUM 0143-4160 32 1 1-10
Hayashi K et al. Angiotensin II interacts with prostaglandin F-2 alpha and endothelin-1 as a local luteolytic factor in the bovine corpus luteum in vitro. (1999) BIOLOGY OF REPRODUCTION 0006-3363 1529-7268 60 5 1104-1109
Hagemann A. Solution of methodological problems in prorenin measurement and investigations of tissue renin-angiotensin systems in the female reproductive tract. (1997) DANISH MEDICAL BULLETIN 0907-8916 1603-9629 2245-1919 44 5 486-498
Ferguson AV et al. Dissociated adult rat subfornical organ neurons maintain membrane properties and angiotensin responsiveness for up to 6 days. (1997) NEUROENDOCRINOLOGY 0028-3835 1423-0194 66 6 409-415
THOMAS WG et al. STABLE EXPRESSION OF A TRUNCATED AT(1A) RECEPTOR IN CHO-KI CELLS - THE CARBOXYL-TERMINAL REGION DIRECTS AGONIST-INDUCED INTERNALIZATION BUT NOT RECEPTOR SIGNALING OR DESENSITIZATION. (1995) JOURNAL OF BIOLOGICAL CHEMISTRY 0021-9258 1083-351X 270 1 207-213
SPENCE SG et al. EVALUATION OF THE REPRODUCTIVE AND DEVELOPMENTAL TOXICITY OF THE AT(1)-SELECTIVE ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN IN RATS. (1995) TERATOLOGY 0040-3709 1096-9926 1542-0760 51 6 383-397
BARKER S et al. EFFECTS OF THE SELECTIVE PROTEIN-KINASE-C INHIBITOR RO-31-7549 ON HUMAN ANGIOTENSIN-II RECEPTOR DESENSITIZATION AND INTRACELLULAR CALCIUM-RELEASE. (1995) FEBS LETTERS 0014-5793 1873-3468 369 2-3 263-266
Nemeth G et al. The Basis and Evidence of a Role for the Ovarian Renin-Angiotensin System in Health and Disease. (1994) JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION 1071-5576 1556-7117 1933-7191 1 2 118-127,
2344410
Celik O et al. Angiotensin-converting enzyme gene polymorphism and risk of insulin resistance in PCOS. (2010) REPRODUCTIVE BIOMEDICINE ONLINE: AN INTERNATIONAL JOURNAL DEVOTED TO BIOMEDICAL RESEARCH ON HUMAN CONCEPTION AND THE WELFARE OF THE HUMAN EMBRYO 1472-6483 1472-6491 20 4 492-498
Okunuki Y et al. Suppression of Experimental Autoimmune Uveitis by Angiotensin II Type 1 Receptor Blocker Telmisartan. (2009) INVESTIGATIVE OPHTHALMOLOGY AND VISUAL SCIENCE 0146-0404 1552-5783 50 5 2255-2261
Harata T et al. Localization of angiotensin II, the AT1 receptor, angiotensin-converting enzyme, aminopeptidase A, adipocyte-derived leucine aminopeptidase, and vascular endothelial growth factor in the human ovary throughout the menstrual cycle. (2006) FERTILITY AND STERILITY 0015-0282 86 2 433-439
Sarlos S et al. The renin-angiotensin system and the developing retinal vasculature. (2005) INVESTIGATIVE OPHTHALMOLOGY AND VISUAL SCIENCE 0146-0404 1552-5783 46 3 1069-1077
Wilkinson-Berka JL. Diabetes and retinal vascular disorders: Role of the renin-angiotensin system. (2004) EXPERT REVIEWS IN MOLECULAR MEDICINE 1462-3994 6 15
Wilkinson-Berka JL et al. Angiotensin and bradykinin: Targets for the treatment of vascular and neuro-glial pathology in diabetic retinopathy. (2004) CURRENT PHARMACEUTICAL DESIGN 1381-6128 1873-4286 10 27 3313-3330
Uncu G et al. The role of plasma renin activity in distinguishing patients with polycystic ovary syndrome (PCOS) from oligomenorrheic patients without PCOS. (2002) GYNECOLOGICAL ENDOCRINOLOGY 0951-3590 1473-0766 16 6 447-452
Hassan E et al. Clinical implications of the ovarian/endometrial renin-angiotensin-aldosterone system. (2000) ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 0077-8923 1749-6632 900 107-118
de Mola JRL et al. Gonadotropins induce higher active renin levels in the follicular fluid of normal and hyperstimulated cycles. (1999) GYNECOLOGICAL ENDOCRINOLOGY 0951-3590 1473-0766 13 3 155-160
EHRMANN DA et al. POLYCYSTIC-OVARY-SYNDROME AS A FORM OF FUNCTIONAL OVARIAN HYPERANDROGENISM DUE TO DYSREGULATION OF ANDROGEN SECRETION. (1995) ENDOCRINE REVIEWS 0163-769X 1945-7189 16 3 322-353
Pepperell JR et al. Intraovarian Regulation by the Ovarian Renin‐Angiotensin System. (1994) AUSTRALIAN AND NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY 0004-8666 1479-828X 34 3 288-292,
2344409
Shuttleworth G et al. In vitro development of pig preantral follicles cultured in a serum-free medium and the effect of angiotensin II. (2002) REPRODUCTION 1470-1626 1741-7899 123 6 807-818
Acosta TJ et al. Periovulatory changes in the local release of vasoactive peptides, prostaglandin F-2 alpha, and steroid hormones from bovine mature follicles in vivo. (2000) BIOLOGY OF REPRODUCTION 0006-3363 1529-7268 63 5 1253-1261
Cannon CM et al. Effect of A23187 or angiotensin II on ovarian metalloproteinase inhibitors and steroidogenesis in rats. (1997) JOURNAL OF REPRODUCTION AND FERTILITY 0022-4251 111 1 71-79
NORMAN J et al. Menstrual regulation by Mifepristone plus prostaglandin: results from a multicentre trial. (1995) HUMAN REPRODUCTION 0268-1161 1460-2350 10 2 308-314,
3145210
Spitz Irving. Mifepristone: where do we come from and where are we going? Clinical development over a quarter of a century. (2010) CONTRACEPTION 0010-7824 82 5 442-452
Chabbert-Buffet N et al. Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications. (2005) HUMAN REPRODUCTION UPDATE 1355-4786 11 3 293-307
Cooper D et al. Medical abortion: The possibilities for introduction in the public sector in South Africa. (2005) REPRODUCTIVE HEALTH MATTERS 0968-8080 13 26 35-43
Chabbert-Buffet N et al. Clinical use of selective progesterone receptor modulators. (2005) Medecine Therapeutique Medecine de la Reproduction, Gynecologie et Endocrinologie 1295-9359 7 2 100-108
Ho PC et al. Mifepristone: contraceptive and non-contraceptive uses. (2002) CURRENT OPINION IN OBSTETRICS & GYNECOLOGY 1040-872X 1473-656X 14 3 325-330
Baird DT. Medical abortion in the first trimester. (2002) BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY 1521-6934 1532-1932 16 2 221-236
Baird DT et al. The science, medicine, and future of contraception (Reprinted from BMJ, vol 319, pg 969-972, 1999). (2000) WESTERN JOURNAL OF MEDICINE 0093-0415 172 5 321-324
Shoupe D. Contraceptive vaginal rings, antiprogestins, and hysteroscopic tubal ligation. (2000) INFERTILITY AND REPRODUCTIVE MEDICINE CLINICS OF NORTH AMERICA 1047-9422 11 4 729-741
Baird DT et al. Science, medicine, and the future - Contraception. (1999) BRITISH MEDICAL JOURNAL (BMJ) 0959-535X 1756-1833 0959-8138 0959-8146 319 7215 969-972
Swahn ML et al. Once-a-month treatment with a combination of mifepristone and the prostaglandin analogue misoprostol. (1999) HUMAN REPRODUCTION 0268-1161 1460-2350 14 2 485-488
Spitz IM et al. Mechanism of action and clinical effects of antiprogestins on the non-pregnant uterus. (1998) HUMAN REPRODUCTION UPDATE 1355-4786 4 5 584-593
Nayak NR et al. Effects of luteal phase administration of mifepristone (RU486) and prostaglandin analogue or inhibitor on endometrium in the rhesus monkey. (1998) HUMAN REPRODUCTION 0268-1161 1460-2350 13 4 1047-1056
Ghosh D et al. Effect of single-dose early luteal phase administration of mifepristone (RU486) on implantation stage endometrium in the rhesus monkey. (1996) HUMAN REPRODUCTION 0268-1161 1460-2350 11 9 2026-2035
Spitz IM et al. Antiprogestins: Mechanism of action and contraceptive potential. (1996) ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY 0362-1642 36 47-81
Pepperell JR et al. The ovarian renin-angiotensin system: A paracrine-intracrine regulator of ovarian function. (1995) ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 0065-2598 377 379-389,
2346088
Liu Y et al. Activation of the aldosterone/mineralocorticoid receptor system and protective effects of mineralocorticoid receptor antagonism in retinal ischemia-reperfusion injury. (2012) EXPERIMENTAL EYE RESEARCH 0014-4835 1096-0007 96 1 116-123
Acosta TJ et al. Local changes in blood flow within the preovulatory follicle wall and early corpus luteum in cows. (2003) REPRODUCTION 1470-1626 1741-7899 125 759-767
Strain WD. The renin-angiotensin-aldosterone system and the eye in diabetes. (2002) JRAAS - Journal of the Renin-Angiotensin-Aldosterone System 3 4 243-246
Wilkinson-Berka JL et al. The interaction between the renin-angiotensin system and vascular endothelial growth factor in the pathogenesis of retinal neovascularization in diabetes. (2001) JOURNAL OF VASCULAR RESEARCH 1018-1172 1423-0135 38 6 527-535
Mikuni M et al. Saralasin-induced inhibition of ovulation in the in vitro perfused rat ovary is not replicated by the angiotensin II type-2 receptor antagonist PD123319. (1998) AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 0002-9378 1097-6868 179 1 35-40
Conley AJ et al. The role of cytochrome P450 170α-hydroxylase and 3β-hydroxysteroid dehydrogenase in the integration of gonadal and adrenal steroidogenesis via the Δ5 and Δ4 pathways of steroidogenesis in mammals. (1997) BIOLOGY OF REPRODUCTION 0006-3363 1529-7268 56 4 789-799
Brunswig-Spickenheier B et al. Stimulation of nitric oxide-cyclic guanosine monophosphate pathway in bovine ovarian theca cells by tumor necrosis factor α (TNFα). Is this pathway implicated in the TNFα-induced inhibition of luteinizing hormone- stimulated prorenin production?. (1997) BIOLOGY OF REPRODUCTION 0006-3363 1529-7268 57 4 700-706
Bramucci M et al. Different modulation of steroidogenesis and prostaglandin production in frog ovary in vitro by ACE and ANG II. (1997) AMERICAN JOURNAL OF PHYSIOLOGY: REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY 0363-6119 1522-1490 273 6 R2089-R2096
Mukhopadhyay AK et al. Follicular maturation and atresia - Possible role of intraovarian regulatory factors. (1996) JOURNAL OF REPRODUCTION AND FERTILITY 0022-4251 105-112
Diano S et al. Mitochondrial uncoupling protein 2 (UCP2) in the nonhuman primate brain and pituitary. (2000) ENDOCRINOLOGY 0013-7227 1945-7170 141 11 4226-4238,
2344415
Bartolome Fernando et al. Endothelial-specific deficiency of megalin in the brain protects mice against high-fat diet challenge. (2020) JOURNAL OF NEUROINFLAMMATION 1742-2094 17 1
de Oliveira Bristot Viviane Jose et al. The Role of PGC-1 alpha/UCP2 Signaling in the Beneficial Effects of Physical Exercise on the Brain. (2019) FRONTIERS IN NEUROSCIENCE 1662-4548 1662-453X 13
Bordt Evan A. et al. Mitochondria, Oxytocin, and Vasopressin: Unfolding the Inflammatory Protein Response. (2019) NEUROTOXICITY RESEARCH 1029-8428 1476-3524 36 2 239-256
Rothan Hussin A. et al. An Overview on the Role of Oligodendrocytes and Mitochondria in the Progression of Multiple Sclerosis. (2018) NEUROCHEMICAL JOURNAL 1819-7124 1819-7132 12 3 205-209
Heise Verena et al. Uncoupling protein 2 haplotype does not affect human brain structure and function in a sample of community-dwelling older adults. (2017) PLOS ONE 1932-6203 1932-6203 12 8
Diaz-Maroto Cicuendez I et al. The UCP2-866G/A Polymorphism Could be Considered as a Genetic Marker of Different Functional Prognosis in Ischemic Stroke After Recanalization. (2017) NEUROMOLECULAR MEDICINE 1535-1084 19 4 571-578
Tekin Suat et al. The effects of intracerebroventricular infusion of irisin on feeding behaviour in rats. (2017) NEUROSCIENCE LETTERS 0304-3940 1872-7972 645 25-32
Erden Yavuz et al. Effects of central irisin administration on the uncoupling proteins in rat brain. (2016) NEUROSCIENCE LETTERS 0304-3940 1872-7972 618 6-13
Normoyle Kieran P et al. THE EMERGING NEUROPROTECTIVE ROLE OF MITOCHONDRIAL UNCOUPLING PROTEIN-2 IN TRAUMATIC BRAIN INJURY. (2015) TRANSLATIONAL NEUROSCIENCE 2081-3856 6 1 179-186
Wang D et al. HIPPOCAMPAL UCP2 IS ESSENTIAL FOR COGNITION AND RESISTANCE TO ANXIETY BUT NOT REQUIRED FOR THE BENEFITS OF EXERCISE. (2014) NEUROSCIENCE 0306-4522 1873-7544 277 36-44
Wu C-H. Progress in research of uncoupling protein in cerebral ischemia. (2012) ZHONGGUO XINYAO ZAZHI / CHINESE JOURNAL OF NEW DRUGS 1003-3734 21 6 623-627+653